| A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy (NCT07675135) | Harmony Biosciences Management, Inc. | 2026-06-04 |
| A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) (NCT07500090) | Harmony Biosciences Management, Inc. | 2026-03-16 |
| A Study of Pitolisant in Participants With Prader-Willi Syndrome (NCT07219485) | Harmony Biosciences Management, Inc. | 2025-08-20 |
| Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates (NCT06930872) | Harmony Biosciences Management, Inc. | 2025-06-06 |
| A Study of HBS-201 (Pitolisant Delayed-release) (NCT07051252) | Harmony Biosciences Management, Inc. | 2025-05-21 |
| A Study of Pitolisant in Patients With Prader-Willi Syndrome (NCT06366464) | Harmony Biosciences Management, Inc. | 2024-05-28 |
| A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia (NCT05458128) | Harmony Biosciences Management, Inc. | 2022-08-19 |
| A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia (NCT05156047) | Harmony Biosciences Management, Inc. | 2022-05-25 |
| WAKIX® (Pitolisant) Pregnancy Registry (NCT05536011) | Harmony Biosciences Management, Inc. | 2021-08-24 |
| Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 (NCT04886518) | Harmony Biosciences Management, Inc. | 2021-06-28 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension (NCT04257929) | Harmony Biosciences Management, Inc. | 2020-12-09 |